Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma

PURPOSE: To determine whether [(18)F]FDG PET/CT-derived radiomic features alone or in combination with clinical, laboratory and biological parameters are predictive of 2-year progression-free survival (PFS) in patients with mantle cell lymphoma (MCL), and whether they enable outcome prognostication....

Descripción completa

Detalles Bibliográficos
Autores principales: Mayerhoefer, Marius E., Riedl, Christopher C., Kumar, Anita, Gibbs, Peter, Weber, Michael, Tal, Ilan, Schilksy, Juliana, Schöder, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879438/
https://www.ncbi.nlm.nih.gov/pubmed/31286200
http://dx.doi.org/10.1007/s00259-019-04420-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879438/
https://www.ncbi.nlm.nih.gov/pubmed/31286200
http://dx.doi.org/10.1007/s00259-019-04420-6

Ejemplares similares